IG
Incisive Genetics is developing a targeted delivery platform for genetic therapies that utilizes lipid nanoparticles to enhance the precision and efficacy of gene editing. This technology aims to improve the accessibility and effectiveness of treatments for genetic disorders by ensuring that therapeutic agents reach their intended cellular targets.
Updated 4 months ago
Funding
$12.3M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- Incisive Genetics is developing a targeted delivery platform for genetic therapies that utilizes lipid nanoparticles to enhance the precision and efficacy of gene editing. This technology aims to improve the accessibility and effectiveness of treatments for genetic disorders by ensuring that therapeutic agents reach their intended cellular targets.